Squamous cell carcinoma (oral manifestation): a case report
https://doi.org/10.33925/1683-3759-2025-1096
Abstract
Relevance. Squamous cell carcinoma of the oral mucosa is a highly aggressive malignancy with a poor prognosis, primarily due to delayed diagnosis. A high index of suspicion among dentists of all specialties facilitates early detection and timely referral to oncology specialists.
Clinical case description. This article presents a case report of squamous cell carcinoma affecting the mandibular alveolar ridge and sublingual mucosa in a female patient. For six months, she had been receiving dental treatment for a painful oral ulcer, gingival bleeding, and tooth mobility.
Conclusion. Thorough patient evaluation and timely recognition of signs of malignant transformation are essential for dental practitioners, enabling earlier intervention and potentially less extensive oncologic surgery.
About the Authors
E. A. VolkovRussian Federation
Evgeny A. Volkov, DMD, Professor, Department of the Restorative Dentistry and Periodontology
4 Dolgorukovskaya Str., Moscow, Russian Federation, 127006
A. P. Polyakov
Russian Federation
Andrey P. Polyakov, DDS, PhD, DSc, Professor, Head of the Department of Maxillofacial surgery and microsurgery
Moscow
O. M. Vasyukova
Russian Federation
Olga M. Vasyukova, DMD, PhD, Docent, Assistant Professor, Department of the Restorative Dentistry and Periodontics
Moscow
E. S. Slazhneva
Russian Federation
Ekaterina S. Slazhneva, DMD, PhD, Associate Professor, Department of the Restorative Dentistry and Periodontology
Moscow
O. A. Bazikyan
Russian Federation
Olga A. Bazikyan, DMD, PhD, Associate Professor, Department of the Oral Surgery and Implantology
Moscow
V. G. Atrushkevich
Russian Federation
Victoria G. Atrushkevich, DMD, PhD, DSc, Professor, Head of the Department of Restorative Dentistry and Periodontology, Vice-President of RPA
Moscow
References
1. Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. Med Sci (Basel). 2023;11(2):42. doi: 10.3390/medsci11020042
2. Høxbroe Michaelsen S, Grønhøj C, Høxbroe Michaelsen J, Friborg J, von Buchwald C. Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients. Eur J Cancer. 2017;78:91-102. doi: 10.1016/j.ejca.2017.03.006
3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. 71(3):209–249. doi: 10.3322/caac.21660
4. Kaprin AD, Starinsky BB, Shakhzadova AO, editors. Malignant neoplasms in Russia in 2023 (morbidity and mortality). Moscow: P.A. Herzen MNIOI – branch of FGBU ‘NMC Radiology’ of the Ministry of Health of Russia; 2024.276 p. (In Russ.). Available from: https://oncology-association.ru/wp-content/up-loads/2024/08/zis-2023-elektronnaya-versiya.pdf
5. Rabinovich OF, Rabinovich IM, Babichenko II, Umarova KV, Bekmurzova LF. Precancers of the oral mucosa: clinic, diagnostics. Stomatology. 2024;103(2):5-11 (In Russ.). doi: 10.17116/stomat20241030215
6. 6 Yang J, Guo K, Zhang A, Zhu Y, Li W, Yu J, et al. Survival analysis of age-related oral squamous cell carcinoma: a population study based on SEER. Eur J Med Res. 2023;28(1):413. doi: 10.1186/s40001-023-01345-7
7. Huber MA, Tantiwongkosi B. Oral and oropharyngeal cancer. Med Clin North Am. 2014;98(6):1299-1321. doi: 10.1016/j.mcna.2014.08.005
8. Conway DI, Purkayastha M, Chestnutt IG. The changing epidemiology of oral cancer: definitions, trends, and risk factors. Br Dent J. 2018;225(9):867-873. doi: 10.1038/sj.bdj.2018.922
9. Li C, Dong X, Li B. Tumor microenvironment in oral squamous cell carcinoma. Front Immunol. 2024;15:1485174. doi: 10.3389/fimmu.2024.1485174
10. Khamis A, Salzer L, Schiegnitz E, Stauber RH, Gül D. The Magic Triangle in Oral Potentially Malignant Disorders: Vitamin D, Vitamin D Receptor, and Malignancy. Int J Mol Sci. 2023;24(20):15058. doi: 10.3390/ijms242015058
11. Khijmatgar S, Yong J, Rübsamen N, Lorusso F, Rai P, Cenzato N, et al. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis. Jpn Dent Sci Rev. 2024;60:32-39. doi: 10.1016/j.jdsr.2023.10.003
12. Jagadeesan D, Sathasivam KV, Fuloria NK, Balakrishnan V, Khor GH, Ravichandran M, et al. Comprehensive insights into oral squamous cell carcinoma: Diagnosis, pathogenesis, and therapeutic advances. Pathol Res Pract. 2024;261:155489. doi: 10.1016/j.prp.2024.155489
13. Artamonova EV, Besova NS, Bolotina LV, Vladimirova LYu, Zhukova LG, Ignatova EO, et al. Russian consensus on prevention, diagnosis and treatment of gastric cancer. Systemic therapy issues. Malignant tumours. 2025;15(1):76–85 (In Russ.). doi: 10.18027/2224-5057-2025-036
14. Nadeau C, Kerr AR. Evaluation and Management of Oral Potentially Malignant Disorders. Dent Clin North Am. 2018;62(1):1-27. doi: 10.1016/j.cden.2017.08.001
15. Güneri P, İlhan B, Bolukbasi G, Veral A, Epstein JB. Is Dysplasia the Sole Determinant of the Prognosis in Oral Potentially Malignant Disorders? J Oral Pathol Med. 2025;54(4):248-250. doi: 10.1111/jop.13617
16. Hankinson P, Mahmood H, Walsh H, Speight PM, Khurram SA. Demystifying oral epithelial dysplasia: a histological guide. Pathology. 2024;56(1):11-23. doi: 10.1016/j.pathol.2023.10.002
17. Nissanka-Jayasuriya EH, Fenton TR, Rose-Zerilli MJJ. Molecular landscape of proliferative verrucous leukoplakia: a systematic review. Br J Oral Maxillofac Surg. 2024;62(2):118-127. doi: 10.1016/j.bjoms.2023.11.012
18. Clarkson E, Hadioonzadeh R, Peters SM. Treatment of Oral Dysplasia. Dent Clin North Am. 2024;68(1):133-149. doi: 10.1016/j.cden.2023.07.008
19. Anjum B, Singh G, Pappu S, Soorneedi N, Likitha B, Kommalapati V. To Evaluate the Level of Awareness of Patients About Existing Oral Precancerous Lesions: A Longitudinal Study. J Pharm Bioallied Sci. 2023;15(Suppl 1):S566-S570. doi: 10.4103/jpbs.jpbs_31_23
20. Li HX, Gong YW, Yan PJ, Xu Y, Qin G, Wen WP, et al. Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy. Front Immunol. 2024 29;15:1453753. doi: 10.3389/fimmu.2024.1453753
21. Zhou J, Hu Z, Wang L, Hu Q, Chen Z, Lin T, et al. Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma. Microbiome. 2024;12(1):193. doi: 10.1186/s40168-024-01907-9
22. Rai AK, Panda M, Das AK, Rahman T, Das R, Das K, et al. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation. Arch Microbiol. 2021;203(1):137-152. doi: 10.1007/s00203-020-02011-w
23. Han Z, Hu Y, Lin X, Cheng H, Dong B, Liu X, et al. Systematic analyses uncover robust salivary microbial signatures and host-microbiome perturbations in oral squamous cell carcinoma. mSystems. 2025;10(2):e0124724. doi: 10.1128/msystems.01247-24
Review
For citations:
Volkov EA, Polyakov AP, Vasyukova OM, Slazhneva ES, Bazikyan OA, Atrushkevich VG. Squamous cell carcinoma (oral manifestation): a case report. Parodontologiya. 2025;30(2):205-211. (In Russ.) https://doi.org/10.33925/1683-3759-2025-1096